98%
921
2 minutes
20
Objectives: In recent years, non-invasive stimulation technologies such as repetitive transcranial magnetic stimulation, transcranial direct current stimulation, bioresonance and auriculotherapy have been used for smoking cessation. Individuals may face various challenges throughout the quitting process. This study aimed to explore the challenges of smoking cessation for users of non-invasive stimulation technologies in Iran.
Design, Setting And Participants: This parallel-convergent mixed-methods study was conducted using both quantitative and qualitative components. In the quantitative component, a cross-sectional study involved 400 participants, randomly and proportionally sampled from clinics offering non-invasive stimulation technologies for smoking cessation. Data were collected through questionnaires on sociodemographic characteristics and the Challenges to Stopping Smoking scale, with descriptive statistics used for analysis. Participants ranked the challenges based on a predetermined list in the quantitative component. In the qualitative component, 25 users from Tehran, Tabriz and Karaj were selected via purposive and snowball sampling. Data were gathered through in-depth, semistructured individual interviews and analysed using qualitative content analysis with a conventional approach. A merging strategy and convergence model were employed to combine the quantitative and qualitative data.
Results: Quantitative results indicated that 71.5% of participants ranked fear of side effects as a major challenge, making it the most significant issue. Qualitative data also highlighted this, as the primary challenge in smoking cessation. 242 (60.5%) participants declared fear of failure as one of the main challenges. Qualitative data indicated that this often stems from previous unsuccessful quit attempts. The feeling of losing cigarettes was one of the major challenges for 129 (32.2%) participants, reflecting a deep emotional dependency on smoking. While the concern about the cost of using the technology was one of the major challenges for 76 (19.0%) of the participants, qualitative data provided a different perspective, with some participants assessing the high cost of quitting against potential future savings from not buying cigarettes. Fear of relapse was a notable challenge identified in the qualitative data, underscoring the importance of managing triggers and environments during the cessation process.
Conclusions: Fear of side effects and failure were the most significant challenges in smoking cessation using non-invasive stimulation technologies. Emotional dependency on cigarettes and concerns about the cost also played a role. Fear of relapse was highlighted in qualitative data. To overcome the challenges of smoking cessation with non-invasive stimulation technologies, supportive programmes that provide psychological counselling, financial aid and education are essential to improve success rates.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683994 | PMC |
http://dx.doi.org/10.1136/bmjopen-2024-091253 | DOI Listing |
Nutr Metab Cardiovasc Dis
August 2025
Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Background And Aims: Although secondhand smoke (SHS) exposure has been linked with metabolic syndrome (MetS) in never-smokers, its effects among individuals who have quit smoking remain unclear. This study investigated the relationship between changes in SHS exposure and incident MetS in a large cohort of Korean former smokers.
Methods And Results: We analyzed 17,269 Korean former smokers without MetS at baseline from a longitudinal cohort, with a median follow-up of three years.
Nicotine Tob Res
September 2025
College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States.
Introduction: Nicotine pouches (NPs) are an emerging nicotine delivery system. Understanding nicotine and toxicant exposure among NP users compared with users of other tobacco products and non-users is critical for informing public health strategies.
Methods: Data (n = 4527) were drawn from the Population Assessment of Tobacco and Health Study Wave 7 (2022-2023).
BMJ Public Health
September 2025
School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Introduction: Curbing adolescent vaping is a public health priority and little evidence exists examining protective factors. Using a strength-based approach, this study explored the relationship between adolescent vaping health perceptions and vaping use.
Methods: Cross-sectional data from 9000 Australian adolescents aged 14-17 years recruited via multiple online panels as part of the Generation Vape Study were used.
J Nurs Scholarsh
September 2025
Health District Northeast Jaén, Andalusian Health Service, Úbeda, Jaén, Spain.
Introduction: Smoking is the leading cause of preventable deaths. The training of professionals on brief tobacco interventions (BTIs) increases the effectiveness of these interventions.
Objective: To assess the effectiveness of an online training program on BTI based on the 5As and 5Rs model in acquiring anti-tobacco brief advice competencies among nurses.
BMJ Open
September 2025
Faculty of Health and Medicine, Lancaster University Medical School, Lancaster, UK.
Introduction: Vaping among children and young people (CYP) has increased globally over the past decade, with rates stabilising in the UK in recent years. Factors such as curiosity, social influence, stress management and attractive flavours contribute to its popularity. Although the long-term health impacts are uncertain, vaping poses risks including nicotine dependence, cardiovascular and respiratory issues, and cognitive impairment, though evidence on long-term effects is still emerging.
View Article and Find Full Text PDF